Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Multi-site, open-label, first-in-human study with 2 parts (dose escalation and dose expansion) in subjects with selected advanced solid tumours

Participants needed: 315
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Orion Corporation, Orion PharmaUpdated: May 8, 2026Locations: 20
Eligibility criteria

Male or female subjects ≥18 years old [+18]

Other malignancy active within the previous 2 years except for basal cell or squ... [+21]

Status: Recruiting

A 2-part Phase 1/2 Open-label Trial on ODM-212

An open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)

Participants needed: 229
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Orion Corporation, Orion PharmaUpdated: May 4, 2026Locations: 2
Eligibility criteria

Male or female participants ≥18 years old. [+14]

Other malignancy active within the previous 2 years except for basal cell or squ... [+14]